Back to results
US 2012/0232105 A1Published application
Pharmaceutical composition for inhibiting osteoclast growth
AssigneeNational Defense Medical Center
InventorsDeh-Ming CHANG, Hsu-Shan Huang
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for inhibiting osteoclast growth is disclosed in the present invention. The pharmaceutical composition includes a compound represented by a formula (I), and a pharmaceutically acceptable salt and carrier: wherein R1, R2, R3, R4 can be one selected from a group consisting of hydrogen, halogen, C1≈C10 alkyl group, C2≈C10 alkynyl group, amino group, haloalkyl group and sulfonamide group.
Claims16
A pharmaceutical composition for inhibiting osteoclast growth includes a compound represented by a formula (I) and a pharmaceutically acceptable salt and carrier:
- wherein R1, R2, R3, R4 can be one selected from a group consisting of hydrogen, halogen, C1≈C10 alkyl group, C2≈C10 alkynyl group, amino group, haloalkyl group and sulfonamide group.
Dependencies are inferred from the claim text.